Stephen K. Carter

Dr. Carter joins Callisto after an extensive career in the area of cancer drug development and research, as both a senior executive and director, and as a medical researcher. Dr. Carter most recently served as Senior Vice President of Clinical and Regulatory Affairs for SUGEN, Inc., a San Francisco-based biotechnology and pharmaceutical company, now a subsidiary of Pfizer. Prior to SUGEN, he held positions including Senior Vice President, Research & Development, for Boehringer Ingelheim Pharmaceuticals, Inc., and Senior Vice President, Woldwide Clinical Research & Development, for Bristol-Myers Squibb Co. Dr. Carter, a former clinical professor of medicine at Stanford University and medical journal author, received a medical degree from New York Medical College, and a bachelor’s degree in American history from Columbia College. He is also a member of numerous cancer-related societies, including the American Society of Clinical Oncology, American Association for Cancer Research, the Society for Surgical Oncology, and the American Society of Pharmacology and Experimental Therapeutics.